NCT07126015Not yet recruiting
Predicting Biologic Therapy Success in Ulcerative Colitis Using Intestinal Ultrasound and Fat Assessment
Predicting Biological Therapy Effectiveness in Ulcerative Colitis Patients Using Intestinal Ultrasound and Visceral Fat Assessment: A Prospective Study
Source: ClinicalTrials.gov · Last updated 7 Jan 2026
Brief summary (registry, in English)
Our study aimed to detecting biological therapy effectiveness in UC patients using visceral fat assessment
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 3 Aug 2025
- Start date
- 1 Jan 2026
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- Assiut University
- Diseases
- Ulcerative colitis
- NCT number
- NCT07126015
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Jan 2026 to the primary completion date, 1 Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous colectomy.
Age
- Patients with UC who are under age of 18 years old.
Other
- Pregnancy.
- Patient refuse to participate in the study
Who the study is looking for
- Any patient above age of 18 years old and diagnosed to have active UC through
- Clinical features: rectal bleeding, with frequent stools and mucous discharge from the rectum. Some patients also describe tenesmus. The onset is typically insidious.
- Endoscopic findings include the following; loss of vascular pattern, Granular and fragile mucosa, friability, ulcerations, erosions, pseudo-polyposis.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.